Resultados de búsqueda - Wasaburo Koizumi
- Mostrando 1 - 20 Resultados de 20
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer por Wasaburo Koizumi, Satoshi Tanabe, Katsunori Saigenji, Atsushi Ohtsu, Narikazu Boku, Fumio Nagashima, Kuniaki Shirao, Yasuhiro Matsumura, Mitsukazu Gotoh
Publicado 2003Artigo -
8
Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center por Satoshi Tanabe, Kenji Ishido, Katsuhiko Higuchi, Tohru Sasaki, Chikatoshi Katada, Mizutomo Azuma, Akira Naruke, Myung‐Chul Kim, Wasaburo Koizumi
Publicado 2013Artigo -
9
Phase <scp>II</scp> trial of nanoparticle albumin‐bound paclitaxel as second‐line chemotherapy for unresectable or recurrent gastric cancer por Yasutsuna Sasaki, Tomohiro Nishina, Hirofumi Yasui, Masahiro Goto, Kei Muro, Akihito Tsuji, Wasaburo Koizumi, Yasushi Toh, Takuo Hara, Yoshinori Miyata
Publicado 2014Artigo -
10
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis por Takahide Nakazawa, Hisashi Hidaka, Akitaka Shibuya, Yusuke Okuwaki, Yoshiaki Tanaka, Juichi Takada, Tsutomu Minamino, Masaaki Watanabe, Shigehiro Kokubu, Wasaburo Koizumi
Publicado 2014Artigo -
11
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer por Kensei Yamaguchi, Masahiro Tada, N Horikoshi, Toru Otani, Hiroya Takiuchi, Soh Saitoh, Ryunosuke Kanamaru, Yasushi Kasai, Wasaburo Koizumi, Yuh Sakata, T Taguchi
Publicado 2002Artigo -
12
Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes por Kosuke Okuwaki, Mitsuhiro Kida, Tetuo Mikami, Hiroshi Yamauchi, Hiroshi Imaizumi, Shiro Miyazawa, Tomohisa Iwai, Miyoko Takezawa, Makoto Saegusa, Masahiko Watanabe, Wasaburo Koizumi
Publicado 2013Artigo -
13
Pharmacodynamic Studies of Gefitinib in Tumor Biopsy Specimens From Patients With Advanced Gastric Carcinoma por Federico Rojo, Josep Tabernero, Joan Albanell, Eric Van Cutsem, Atsushi Ohtsu, Toshihiko Doi, Wasaburo Koizumi, Kuniaki Shirao, Hiroya Takiuchi, Santiago Ramón y Cajal, José Baselga
Publicado 2006Artigo -
14
Endoscopic ultrasonography diagnosis of subepithelial lesions por Mitsuhiro Kida, Yusuke Kawaguchi, Eiji Miyata, Rikiya Hasegawa, Toru Kaneko, Hiroshi Yamauchi, Shuko Koizumi, Kosuke Okuwaki, Shiro Miyazawa, Tomohisa Iwai, Hidehiko Kikuchi, Maya Watanabe, Hiroshi Imaizumi, Wasaburo Koizumi
Publicado 2017Revisão -
15
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib por Haruki Uojima, Makoto Chuma, Yoshiaki Tanaka, Hisashi Hidaka, Takahide Nakazawa, Shogo Iwabuchi, Satoshi Kobayashi, Nobuhiro Hattori, Katsuaki Ogushi, Manabu Morimoto, Tatehiro Kagawa, Katsuaki Tanaka, Makoto Kako, Wasaburo Koizumi
Publicado 2019Artigo -
16
Genotype‐directed, dose‐finding study of irinotecan in cancer patients with <i>UGT1A1*28</i> and/or <i>UGT1A1*6</i> polymorphisms por Taroh Satoh, Takashi Ura, Yasuhide Yamada, Kentaro Yamazaki, Toshimasa Tsujinaka, Masaki Munakata, Tomohiro Nishina, Shu Okamura, Taito Esaki, Yasutsuna Sasaki, Wasaburo Koizumi, Yoshihiro Kakeji, Naoki Ishizuka, Ichinosuke Hyodo, Yuh Sakata
Publicado 2011Artigo -
17
Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912 por Daisuke Takahari, Narikazu Boku, Junki Mizusawa, Atsuo Takashima, Yasuhide Yamada, Takayuki Yoshino, Kentaro Yamazaki, Wasaburo Koizumi, Kazutoshi Fukase, Kensei Yamaguchi, Masahiro Goto, Tomohiro Nishina, Takao Tamura, Akihito Tsuji, Atsushi Ohtsu
Publicado 2014Artigo -
18
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer por Kensei Yamaguchi, T Shimamura, Ichinosuke Hyodo, Wasaburo Koizumi, Toshihiko Doi, H. Narahara, Yoshito Komatsu, Takeshi Kato, Satoshi Saitoh, Toshikazu Akiya, Masaki Munakata, Yoshinori Miyata, Yoshiharu Maeda, Hiroya Takiuchi, S Nakano, Taito Esaki, Fukunori Kinjo, Yuh Sakata
Publicado 2006Artigo -
19
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START) por Wasaburo Koizumi, Yeul Hong Kim, Masashi Fujii, Hoon Kyo Kim, Hiroshi Imamura, Kyung Hee Lee, Takuo Hara, Hyun Cheol Chung, Taroh Satoh, Y. Choi, Hisashi Hosaka, Akihito Tsuji, Akinori Takagane, Mikito Inokuchi, Kazuaki Tanabe, Tatsuya Okuno, Mariko Ogura, Kazuhiro Yoshida, Masahiro Takeuchi, Toshifusa Nakajima
Publicado 2013Artigo -
20
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial por Atsuo Takashima, Kohei Shitara, Kazumasa Fujitani, Keisuke Koeda, Hiroki Hara, Norisuke Nakayama, Shuichi Hironaka, Kazuhiro Nishikawa, Yutaka Kimura, Kenji Amagai, Hirofumi Fujii, Kei Muro, Taito Esaki, Yasuhiro Choda, Toshimi Takano, Keisho Chìn, Atsushi Satō, Masahiro Goto, Norimasa Fukushima, Takuo Hara, Nozomu Machida, Manabu Ohta, Narikazu Boku, Masashi Shimura, Satoshi Morita, Wasaburo Koizumi
Publicado 2018Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Gastroenterology
Cancer
Surgery
Chemotherapy
Oncology
Neutropenia
Colorectal cancer
Confidence interval
Biology
Hazard ratio
Adverse effect
Cisplatin
Endoscopy
Paclitaxel
Phases of clinical research
Randomized controlled trial
Regimen
Antrum
Biochemistry
Clinical endpoint
Docetaxel
Febrile neutropenia
Gene
Genetics
Hepatocellular carcinoma
Immunohistochemistry
Irinotecan
Leukopenia